Baseline and phosphoramide mustard-induced sister-chromatid exchanges in pharmacists handling anti-cancer drugs

https://doi.org/10.1016/0165-1218(92)90067-AGet rights and content

Abstract

Determinations of baseline and mutagen-induced sister-chromatid exchanges (SCE) have been used as indicators of previous mutagen exposure in several human populations. Mutagen-induced SCE is based on the premise that a genetic outcome may depend not only on a present exposure, but also on a cell's “memory” of previous exposure. The genotoxicity of some anti-cancer drugs including cyclophosphamide (CP) has been studied by determining baseline and mutagen-induced SCE in peripheral blood lymphocytes in treated cancer patients. This study examined the in vivo genotoxic effects of occupational exposure to anti-cancer drug handling by relating baseline and phosphoramide mustard (PM) -induced SCE levels with duration of anti-cancer drug handling as a surrogate for anti-cancer drug exposure dose. The mean baseline SCE for the population was 5.19 ± 0.17 and was not correlated with duration of drug handling. However, a strong correlation was demonstrated between inducible SCE values and life-time duration of drug handling with r = 0.63 (p < 0.0001 for low-dose PM challenge (0.1 mg/ml PM) and r = 0.67 (p < 0.0001) for high-dose PM challenge (0.25 mg/ml PM). A similar relationship was seen for PM-induced SCE and duration of anti-cancer drug handling for the workers' present job with correlations obtained being r = 0.63 (p < 0.0001) for low-dose PM and r = 0.59 (p < 0.0001) for high dose PM. The short-lived nature of the baseline SCE lesion is discussed as a limitation in population surveillance studies, as it reflects primarily recent mutagen exposure and persists only for days to weeks after exposure. The induced SCE measure is postulated to provide an integrating dosimeter of remote previous exposure, improving upon the current limitation of the baseline SCE measure and allowing the “unmasking” of previous exposure in a provocative framework.

References (32)

  • J. Doull et al.

    Casarett and Doull's Toxicology: The Basic Science of Poisons

  • R. Ferguson et al.

    The use within New Zealand of cytogenetic approaches to monitoring of hospital pharmacists for exposure to cytotoxic drugs: Report of a pilot study in Auckland

    Aust. J. Hosp. Pharm.

    (1988)
  • J.P. Frank et al.

    X-Ray induction of persistent hypersensitivity to mutation

    Science

    (1982)
  • M.J. Garrett

    Teratogenic effects of combination chemotherapy

    Ann. Intern. Med.

    (1974)
  • E. Gebhart et al.

    Chromosome studies on lymphocytes of patients under cytostatic therapy, II. Studies using the BUDR-labeling technique in cytostatic interval therapy

    Human Genet.

    (1980)
  • J. Gililland et al.

    The effects of cancer chemotherapeutic agents on the developing fetus

    Obstet. Gynecol. Surv.

    (1983)
  • Cited by (22)

    • Occupational exposures among nurses and risk of spontaneous abortion

      2012, American Journal of Obstetrics and Gynecology
      Citation Excerpt :

      In addition, Nurses' Health Study participants have been shown to self- report health data accurately for several medical conditions.47-49 Moreover, self-report of the duration of drug handling by pharmacists has been shown to be valid.50 However, there is still potential for recall bias, because the pregnancy outcomes were reported on the same instrument that collected occupational exposures.

    • Biological and environmental monitoring of hospital personnel exposed to antineoplastic agents: A review of analytical methods

      2003, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
    • Cyclophosphamide: Review of its mutagenicity for an assessment of potential germ cell risks

      1995, Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
    • Biomonitoring of nurses handling antineoplastic drugs

      1994, Mutation Research/Genetic Toxicology
    View all citing articles on Scopus
    View full text